These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [TBL] [Abstract][Full Text] [Related]
4. Expression of two inward rectifier potassium channels is essential for differentiation of primitive human hematopoietic progenitor cells. Shirihai O; Attali B; Dagan D; Merchav S J Cell Physiol; 1998 Nov; 177(2):197-205. PubMed ID: 9766516 [TBL] [Abstract][Full Text] [Related]
5. The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation. Wang SY; Hsu ML; Huang MZ; Hsu HC; Tzeng CH; Hung JH; Ho CK Acta Haematol; 2001; 105(1):38-44. PubMed ID: 11340252 [TBL] [Abstract][Full Text] [Related]
6. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines. Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224 [TBL] [Abstract][Full Text] [Related]
8. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors. Curti A; Fogli M; Ratta M; Tura S; Lemoli RM J Immunol; 2001 Jan; 166(2):848-54. PubMed ID: 11145659 [TBL] [Abstract][Full Text] [Related]
9. Phenotype and progeny of primitive adherent human hematopoietic progenitors. Gordon MY; Lewis JL; Grand FH; Marley SB; Goldman JM Leukemia; 1996 Aug; 10(8):1347-53. PubMed ID: 8709641 [TBL] [Abstract][Full Text] [Related]
10. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932 [TBL] [Abstract][Full Text] [Related]
11. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures. La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768 [TBL] [Abstract][Full Text] [Related]
13. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857 [TBL] [Abstract][Full Text] [Related]
14. In vitro expansion of CD13+CD33+ dendritic cell precursors from multipotent progenitors is regulated by a discrete fas-mediated apoptotic schedule. Santiago-Schwarz F; Borrero M; Tucci J; Palaia T; Carsons SE J Leukoc Biol; 1997 Oct; 62(4):493-502. PubMed ID: 9335320 [TBL] [Abstract][Full Text] [Related]
15. FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction. Nielsen SD; Husemoen LL; Sørensen TU; Gram GJ; Hansen JE J Hematother Stem Cell Res; 2000 Oct; 9(5):695-701. PubMed ID: 11091493 [TBL] [Abstract][Full Text] [Related]
16. Expansion of cord blood progenitors and use for hemopoietic reconstitution. Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315 [TBL] [Abstract][Full Text] [Related]
17. Peripheral blood cell harvests yield primitive multilineage progenitor cells in the CD34+/33- fraction. Croockewit A; Raymakers RA; Trilsbeek C; Dolstra H; Pennings A; De Witte TJ; Haanen C Int J Artif Organs; 1993 Dec; 16 Suppl 5():83-8. PubMed ID: 7516921 [TBL] [Abstract][Full Text] [Related]
18. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells. Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858 [TBL] [Abstract][Full Text] [Related]
19. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]